Emond P, Garreau L, Chalon S, Boazi M, Caillet M, Bricard J, Frangin Y, Mauclaire L, Besnard J C, Guilloteau D
INSERM U316, Laboratoire de Biophysique Médicale et Pharmaceutique, Tours, France.
J Med Chem. 1997 Apr 25;40(9):1366-72. doi: 10.1021/jm960795d.
Two novel series of iodinated N-substituted analogs of 2beta-carbomethoxy-3beta-(4'-iodophenyl)tropane (beta-CIT) and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-dis ubstituted phenyl)nortropane were synthesized. They were evaluated for their inhibitory properties on dopamine (DA(T)), serotonin (5-HT(T)), and norepinephrine (NE(T)) transporters in rat brain homogenates using [3H]GBR-12935, [3H]paroxetine, and [3H]nisoxetine as specific ligands. All new N-substituted analogs of beta-CIT exhibited higher DAT selectivity over both 5-HT(T) and NE(T) than beta-CIT. Moreover compounds with the N-substituents propynyl (6), crotyl (4), 2-bromoprop-(2E)-enyl (5), and 3-iodoprop-(2E)-enyl (3d) showed similar to higher DA(T) affinities than beta-CIT (respectively 14, 15, 30, and 30 nM vs 27 nM). Compound 3d was found to be the most selective DA(T) agent of this series (5-HTT/DA(T) = 32.0 vs 0.1 for beta-CIT). The N-(3-iodoprop-(2E)-enyl) chain linked to the tropane nitrogen was therefore maintained on the tropane structure, and phenyl substitution was carried out in order to improve DA(T) affinity. K(i) values of N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-dis ubstituted phenyl)nortropanes revealed that phenyl, 4'-isopropyl, and 4'-n-propyl derivatives weakly inhibited specific binding to DA(T), whereas phenyl substitution with 4'-methyl (3c), 3',4'-dichloro (3b), and 4'-iodo (3d) yielded high-DA(T) reuptake agents with increased DA(T) selectivity compared to beta-CIT. These results demonstrate that the combination of a nitrogen and a phenyl substitution yields compounds with high affinity and selectivity for the dopamine transporter which are usable as SPECT markers for DA neurons.
合成了两个新型系列的2β-甲氧羰基-3β-(4'-碘苯基)托烷(β-CIT)的碘化N-取代类似物以及N-(3-碘丙-(2E)-烯基)-2β-甲氧羰基-3β-(3',4'-二取代苯基)降托烷。使用[3H]GBR-12935、[3H]帕罗西汀和[3H]尼索西汀作为特异性配体,在大鼠脑匀浆中评估了它们对多巴胺(DA(T))、5-羟色胺(5-HT(T))和去甲肾上腺素(NE(T))转运体的抑制特性。所有新的β-CIT的N-取代类似物对DA(T)的选择性均高于β-CIT对5-HT(T)和NE(T)的选择性。此外,具有炔丙基(6)、巴豆基(4)、2-溴丙-(2E)-烯基(5)和3-碘丙-(2E)-烯基(3d)等N-取代基的化合物显示出与β-CIT相似或更高的DA(T)亲和力(分别为14、15、30和30 nM,而β-CIT为27 nM)。发现化合物3d是该系列中最具选择性的DA(T)药物(5-HTT/DA(T) = 32.0,而β-CIT为0.1)。因此,连接在托烷氮上的N-(3-碘丙-(2E)-烯基)链保留在托烷结构上,并进行苯基取代以提高DA(T)亲和力。N-(3-碘丙-(2E)-烯基)-2β-甲氧羰基-3β-(3',4'-二取代苯基)降托烷的K(i)值表明,苯基、4'-异丙基和4'-正丙基衍生物对DA(T)的特异性结合抑制作用较弱,而用4'-甲基(3c)、3',4'-二氯(3b)和4'-碘(3d)进行苯基取代则产生了与β-CIT相比具有更高DA(T)选择性的高DA(T)再摄取药物。这些结果表明,氮取代和苯基取代的组合产生了对多巴胺转运体具有高亲和力和选择性的化合物,可用作DA神经元的SPECT标记物。